Consistency in reporting of primary endpoints (PEP) from registration to publication for modern randomized oncology phase III trials

被引：0
|
作者：
You, B.
Gan, H. K.
Pond, G. R.
Chen, E. X.
机构：
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[2] Austin Hosp, Melbourne, Vic 3084, Australia
[3] McMaster Univ, Hamilton, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.6031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6031
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Consistency in the Analysis and Reporting of Primary End Points in Oncology Randomized Controlled Trials From Registration to Publication: A Systematic Review
    You, Benoit
    Gan, Hui K.
    Pond, Gregory
    Chen, Eric X.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (02) : 210 - 216
  • [2] Consistency in the analysis and reporting of PEPs in oncology randomized controlled trials from registration to publication: a systematic review
    Boespflug, Amelie
    Gan, Hui
    Chen, Eric X.
    Pond, Gregory
    You, Benoit
    BULLETIN DU CANCER, 2012, 99 (10) : 943 - 952
  • [3] Quality of Reporting of Modern Randomized Controlled Trials In Oncology
    Peron, J.
    Pond, G.
    Gan, H. G.
    Chen, E. X.
    Maillet, D.
    You, B.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S167 - S167
  • [4] Prevalence and predictors of bias in the reporting of primary efficacy and toxicity endpoints in randomized clinical trials of radiation oncology
    Tan, Teng Hwee
    Chen, Desiree
    Soon, Yu Yang
    Tey, Jeremy Chee Seong
    Journal of Medical Imaging and Radiation Oncology, 2016, 60 (06) : 764 - 771
  • [5] Selective registration of non-primary endpoints in randomized clinical trials in oncology: a comparison of endpoint reporting between clinical trial protocols and US national clinical trial registration
    Serpas, V.
    Halperin, D.
    Raghav, K.
    Overman, M. J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [6] Primary endpoints of phase III trials for older patients with cancer
    Mizutani, T.
    ANNALS OF ONCOLOGY, 2021, 32 : S1187 - S1187
  • [7] Discrepancies in endpoints between clinical trial protocols and clinical trial registration in randomized trials in oncology
    Victoria J. Serpas
    Kanwal P. Raghav
    Daniel M. Halperin
    James Yao
    Michael J. Overman
    BMC Medical Research Methodology, 18
  • [8] Discrepancies in endpoints between clinical trial protocols and clinical trial registration in randomized trials in oncology
    Serpas, Victoria J.
    Raghav, Kanwal P.
    Halperin, Daniel M.
    Yao, James
    Overman, Michael J.
    BMC MEDICAL RESEARCH METHODOLOGY, 2018, 18
  • [9] Design and reporting of phase III oncology trials with prospective biomarker validation
    Liang, Fei
    Peng, Ling
    Wu, Zhengyu
    Giamas, Georgios
    Stebbing, Justin
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (02): : 174 - 180
  • [10] Quality of Reporting of Modern Randomized Controlled Trials in Medical Oncology: A Systematic Review
    Peron, Julien
    Pond, Gregory R.
    Gan, Hui K.
    Chen, Eric X.
    Almufti, Roula
    Maillet, Denis
    You, Benoit
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (13): : 982 - 989
12345